Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015;11(5):1258-60.
doi: 10.1080/21645515.2015.1021528.

A vaccine against Ebola: Problems and opportunities

Giovanni Rezza  1
Affiliations

A vaccine against Ebola: Problems and opportunities

Giovanni Rezza. Hum Vaccin Immunother. 2015.

Abstract

The unprecedented dimensions of the 2014 Ebola epidemic which ravaged 3 West African countries have challenged public health response capacity and urged the availability of safe and effective vaccines. In this context, vectored vaccines already tested in animal models have undergone phase 1 studies in human beings and are now ready for efficacy evaluation in large scale trials. Health care workers and other frontline caregivers are likely to be the target population for both vaccine trials and vaccination campaigns. However, methodological and ethical issues should be considered in plans concerning the conduction of clinical trials and the possible use of licensed vaccines against Ebola.

Keywords: Ebola; epidemiology; ethics; study design; vectored vaccine.

PubMed Disclaimer

References

    1. WHO Response to the Ebola outbreak. Situation Report, January 21, 2015. http://www.who.int/csr/disease/ebola/situation-reports/en/. Access: January27, 2015
    1. Rezza G. Ebola: when a nightmare becomes reality. Ann Ist Super Sanità 2014; 50:307-8; PMID:25522067; http://dx.doi.org/ 10.4415/ANN_14_04_01 - DOI - PubMed
    1. Sullivan NJ, Sanchez A, Rollin PE, Nabel GJ.. Development of a preventive vaccine for Ebola virus infection in primates. Nature 2000; 408:605-9; PMID:11117750; http://dx.doi.org/ 10.1038/35046108 - DOI - PubMed
    1. Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G, Mulangu S, Hu Z, Andrews CA, Sheets RA, et al.. A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine 2010; 29:304-13; PMID:21034824; http://dx.doi.org/ 10.1016/j.vaccine.2010.10.037 - DOI - PubMed
    1. Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010; 17:1055-65; PMID:20463105; http://dx.doi.org/ 10.1128/CVI.00131-10 - DOI - PMC - PubMed

MeSH terms

LinkOut - more resources